Your search returned 530 results.

Results
	241.	The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair. [electronic resource] by Maiso, P Colado, E Ocio, E M Garayoa, M Martín, J Atadja, P Pandiella, A San-Miguel, J F Producer: 20100114 In: Leukemia vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	242.	Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis. [electronic resource] by DeAngelo, Daniel J Mesa, Ruben A Fiskus, Warren Tefferi, Ayalew Paley, Carole Wadleigh, Martha Ritchie, Ellen K Snyder, David S Begna, Kebede Ganguly, Siddhartha Ondovik, Michael S Rine, Jessica Bhalla, Kapil N Producer: 20130916 In: British journal of haematology vol. 162 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	243.	BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency. [electronic resource] by Pache, Lars Dutra, Miriam S Spivak, Adam M Marlett, John M Murry, Jeffrey P Hwang, Young Maestre, Ana M Manganaro, Lara Vamos, Mitchell Teriete, Peter Martins, Laura J König, Renate Simon, Viviana Bosque, Alberto Fernandez-Sesma, Ana Cosford, Nicholas D P Bushman, Frederic D Young, John A T Planelles, Vicente Chanda, Sumit K Producer: 20160531 In: Cell host & microbe vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	244.	PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma. [electronic resource] by Richardson, Paul G Schlossman, Robert L Alsina, Melissa Weber, Donna M Coutre, Steven E Gasparetto, Cristina Mukhopadhyay, Sutapa Ondovik, Michael S Khan, Mahmudul Paley, Carole S Lonial, Sagar Producer: 20131118 In: Blood vol. 122 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	245.	Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway. [electronic resource] by Pera, Benet Krumsiek, Jan Assouline, Sarit E Marullo, Rossella Patel, Jayeshkumar Phillip, Jude M Román, Lidia Mann, Koren K Cerchietti, Leandro Producer: 20180817 In: EBioMedicine vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	246.	LBH589, A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington's Disease. [electronic resource] by Chopra, Vanita Quinti, Luisa Khanna, Prarthana Paganetti, Paolo Kuhn, Rainer Young, Anne B Kazantsev, Aleksey G Hersch, Steven Producer: 20171023 In: Journal of Huntington's disease vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	247.	Inducible expression of cancer-testis antigens in human prostate cancer. [electronic resource] by Heninger, Erika Krueger, Timothy E G Thiede, Stephanie M Sperger, Jamie M Byers, Brianna L Kircher, Madison R Kosoff, David Yang, Bing Jarrard, David F McNeel, Douglas G Lang, Joshua M Producer: 20180306 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	248.	A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post--polycythemia vera/essential thrombocythemia myelofibrosis (post--PV/ET MF). [electronic resource] by Mascarenhas, J Marcellino, B K Lu, M Kremyanskaya, M Fabris, F Sandy, L Mehrotra, M Houldsworth, J Najfeld, V El Jamal, S Petersen, B Moshier, E Hoffman, R Producer: 20200714 In: Leukemia research vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	249.	In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma. [electronic resource] by Ocio, Enrique M Vilanova, David Atadja, Peter Maiso, Patricia Crusoe, Edvan Fernández-Lázaro, Diego Garayoa, Mercedes San-Segundo, Laura Hernández-Iglesias, Teresa de Alava, Enrique Shao, Wenlin Yao, Yung-Mae Pandiella, Atanasio San-Miguel, Jesús F Producer: 20111005 In: Haematologica vol. 95 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	250.	Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC. [electronic resource] by Mithraprabhu, Sridurga Khong, Tiffany Jones, Simon S Spencer, Andrew Producer: 20131017 In: British journal of haematology vol. 162 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	251.	Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model. [electronic resource] by Singleton, W G Collins, A M Bienemann, A S Killick-Cole, C L Haynes, H R Asby, D J Butts, C P Wyatt, M J Barua, N U Gill, S S Producer: 20170508 In: International journal of nanomedicine vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	252.	Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Puralpha-mediated decrease in androgen receptor levels. [electronic resource] by Liu, Xiaomei Gomez-Pinillos, Alejandro Liu, Xiaojun Johnson, Edward M Ferrari, Anna C Producer: 20100112 In: The Prostate vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	253.	Epigenetic modulation of radiation response in human cancer cells with activated EGFR or HER-2 signaling: potential role of histone deacetylase 6. [electronic resource] by Kim, In Ah No, Mina Lee, Jang Mi Shin, Jin Hee Oh, Jee Sun Choi, Eun Jung Kim, Il Han Atadja, Peter Bernhard, Eric J Producer: 20091027 In: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	254.	The American Society of Hematology--46th Annual Meeting and Exposition. HDAC, Flt and farnesyl transferase inhibitors. [electronic resource] by Evans, Liz Producer: 20050603 In: IDrugs : the investigational drugs journal vol. 8 Availability: No items available. Save to lists Add to cart (remove)
	255.	Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma. [electronic resource] by Drappatz, J Lee, E Q Hammond, S Grimm, S A Norden, A D Beroukhim, R Gerard, M Schiff, D Chi, A S Batchelor, T T Doherty, L M Ciampa, A S Lafrankie, D C Ruland, S Snodgrass, S M Raizer, J J Wen, P Y Producer: 20120601 In: Journal of neuro-oncology vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	256.	The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258. [electronic resource] by Vallo, Stefan Mani, Jens Stastny, Matthias Makarević, Jasmina Juengel, Eva Tsaur, Igor Bartsch, Georg Haferkamp, Axel Blaheta, Roman A Producer: 20130924 In: Investigational new drugs vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	257.	Efficacy of panobinostat and marizomib in acute myeloid leukemia and bortezomib-resistant models. [electronic resource] by Corrales-Medina, Fernando F Manton, Christa A Orlowski, Robert Z Chandra, Joya Producer: 20150507 In: Leukemia research vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	258.	Panobinostat in combination with bortezomib and dexamethasone as induction therapy in patients with multiple myeloma, candidates for autologous transplant. [electronic resource] by Mangiacavalli, Silvia Pochintesta, Lara Ravelli, Erika Baldini, Luca Ferretti, Virginia Valeria La Targia, Maria Luisa Farina, Lucia Cocito, Federica Cairoli, Roberto Montefusco, Vittorio Corso, Alessandro Producer: 20160412 In: Leukemia & lymphoma vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	259.	Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells. [electronic resource] by Hennig, D Müller, S Wichmann, C Drube, S Pietschmann, K Pelzl, L Grez, M Bug, G Heinzel, T Krämer, O H Producer: 20150320 In: British journal of cancer vol. 112 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	260.	A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-PV/ET MF). [electronic resource] by Mascarenhas, John Lu, Min Li, Timmy Petersen, Bruce Hochman, Tsivia Najfeld, Vesna Goldberg, Judith D Hoffman, Ronald Producer: 20130521 In: British journal of haematology vol. 161 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 530 results.